Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

post-transplant lymphoproliferative disease News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A recent study explores post-transplant lymphoproliferative disorder (PTLD) occurring after successful treatment of graft-versus-host disease (GVHD) in liver transplant patients. This research highlights the complexities of managing complications in transplant recipients.

Atara Biotherapeutics Reports that the Resubmitted Tabelecleucel (Tab-cel®) Biologics License Application Has Been Accepted by the U.S. Food and Drug Administration - BioSpace

A national retrospective study examines the clinicopathological landscape of pediatric monomorphic post-transplant lymphoproliferative disorder (PTLD). This research provides insights into the disease's characteristics and may inform future treatment strategies.

A recent case study highlights an uncommon presentation of post-transplant lymphoproliferative disorder in a child following liver transplantation, characterized by massive splenomegaly. This finding contributes to the understanding of rare disease manifestations in pediatric transplant patients.

A rare case report details gastrointestinal-localized polymorphic post-transplant lymphoproliferative disorder following kidney transplantation after allogeneic hematopoietic stem cell transplantation. This case highlights the complexities and potential complications in post-transplant care.

A Finnish nationwide study over 30 years analyzed survival and prognostic factors in 215 cases of post-transplant lymphoproliferative disorders. The findings contribute to understanding outcomes in patients following solid organ transplantation.

Not rare diseases news,news about your rare disease.